Gene Query: TARS

Dataset Description Geneva Score
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 37.27
Differetially expressed genes after hTR overexpression in U2OS cells 35.78
Cleavage Factor Im as a key regulator of 3’ UTR length 32.2
Co-transcriptional loading of RNA export factors shapes the human transcriptome 31.64
RNAseq of HEK293 cells after Chtop knockdown 31.64
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 31.11
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 31.11
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 31.11
Role of microRNAs in the interaction between Salmonella and the host cell 29.65
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 29.39
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 28.78
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 28.17
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 27.72
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 25.48
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 25.06
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 24.9
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 24.67
MARS Seq data from human cortical organoids 24.16
Ebola virus (EBOV) infection of ARPE-19 cells 23.53
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 22.71
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 22.68
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 21.83
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 21.8
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 21.73
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 21.7
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 21.29
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 21.28
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 21.07
Efficient and quantitative high-throughput tRNA sequencing 21.06
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 20.97
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 20.09
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 20.09
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 19.82
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 19.6
Landscape of H3K4me3 in human CD19 cells 19.39
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 19.34
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 19.34
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 19.25
Genes significantly down or Up-regulated upon RNF219 knockdown 18.91
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 18.69
Exogenous rescue of KLHL9 in SF210 cell line 18.68
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 18.4
Differential expression of genes in AD169-infected MRC5. 18.25
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 18.17
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 17.96
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 17.73
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 17.6
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 17.41
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 17.41
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 17.36
Gene Expression Profiling of SPOP Knocked Down Cell 17.14
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 17.14
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 17.13
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 17.08
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 17.08
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 16.81
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 16.66
Identification of global regulators of T-helper cell lineage specification 16.66
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 16.45
3’ Uridylation Expands miRNA Target Repertoire 16.41
Genome wide expression change in LCC2 and MCF-7 cells 15.95
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 15.59
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 15.53
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 15.53
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 15.29
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 15.26
RNA sequencing of primary human platelets and in vitro cell lines 15.17
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 15.01
RNA-Seq with and without RNase treatment in PCa cell lines 15.01
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 14.98
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 14.95
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 14.72
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 14.46
Depicting early human development and germ cell origin with porcine embryos 14.44
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.23
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 14.16
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 14.13
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 14.0
Regulating Interleukin-2 activity with engineered receptor signaling clamps 13.98
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 13.86
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 13.83
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.67
Modeling Familial Cancer with iPSC Approaches 13.51
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 13.47
Transcriptome of U251 cells overexpression complement component 7 13.45
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 13.44
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 13.41
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 13.41
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 13.37
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 13.35
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 13.35
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 13.21
Transcriptome of activated human and mouse MAIT cells 13.21
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 12.93
Transcriptomic analysis of the HOTAIR-regulated genes 12.86
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 12.86
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 12.82
In vitro modeling of human germ cell development using pluripotent stem cells 12.82
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 12.78
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 12.59
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 12.59
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 12.59
Primary Human B-cell Temporal Response to CD40L Stimulation 12.53
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 12.51
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 12.48
RNA-seq of naive and primed ES cells 12.26
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 12.24
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 12.24
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 12.18
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 12.01
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 11.96
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 11.94
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.77
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 11.7
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 11.69
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 11.62
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 11.62
Trans-differentiation of human adult peripheral blood T cells into neurons 11.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 11.18
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 11.17
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 10.99
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 10.99
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 10.96
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 10.93
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.93
Ribosomal footprinting of CN34-Parental and CN34-LM1a 10.87
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 10.76
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 10.71
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 10.71
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 10.71
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 10.56
BI Human Reference Epigenome Mapping Project 10.56
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 10.4
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 10.39
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 10.38
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 10.38
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 10.33
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 10.33
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 10.32
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.29
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 10.23
Hepatitis C virus functionally sequesters miR-122 10.23
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 10.17
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 10.16
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 10.15
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 10.14
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 10.1
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 10.09
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.04
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.99
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 9.94
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 9.92
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 9.89
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.88
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 9.86
RNA-sequencing of human liver tissue 9.83
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 9.82
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 9.74
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 9.73
9.71
Global Mapping of Human RNA-RNA Interactions 9.71
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.66
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 9.64
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 9.63
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 9.59
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 9.58
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.52
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 9.51
Differential Protein Occupancy Profiling of the mRNA Transcriptome 9.49
Ribosomal footprinting of MDA-Parental and MDA-LM2 9.48
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 9.41
Profiling of escape kinetics of viruses subjected to RNAi 9.4
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 9.32
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 9.32
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 9.31
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 9.31
Role of XRN2 ribonucleolytic activity in RNA metabolism 9.21
Molecular Criteria for Defining the Naive Human Pluripotent State 9.2
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 9.2
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 9.2
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 9.19
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 9.19
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 9.15
Transcriptome analysis of Zika infected neural stem cells 9.15
Zika infected neural stem cells 9.15
Single-nucleotide-resolution mapping of HBV promoters using CAGE 9.12
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 9.11
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 9.08
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.06
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.06
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 8.99
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 8.97
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 8.96
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.94
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 8.92
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 8.91
RNA-Seq analysis of breast cancer cells after shikonin treatment 8.9
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 8.85
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 8.84
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 8.84
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 8.81
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 8.76
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 8.75
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.72
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.63
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 8.63
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.6
RNA-seq analysis of AML cells in response to ASLAN003 8.56
Morphological and molecular characterization of human dermal lymphatic collectors 8.51
The human blood-nerve barrier transcriptome 8.49
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 8.42
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 8.42
mRNA expression profile of Lymphocytes 8.42
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 8.29
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 8.21
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 8.21
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 8.19
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.17
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.17
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.17
Determination of tRNA aminoacylation levels by high throughput sequencing 8.14
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.14
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 8.12
RNA transcriptome analysis during HSV-1 infection 8.04
MYC dependent mRNA translation shapes gene expression and cell biology 8.03
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 8.03
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.02
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.01
Differentiation enhances Zika virus infection in neuronal brain cells 7.96
Gene expression analysis of dengue-infected cells 7.94
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 7.87
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 7.86
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 7.84
Exploring the RNA landscape of endothelial exosomes 7.7
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 7.68
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.64
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 7.63
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.59
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 7.55
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 7.54
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 7.5
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 7.5
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 7.47
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 7.46
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 7.46
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 7.45
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 7.45
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 7.44
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 7.42
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 7.37
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 7.36
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 7.33
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 7.28
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 7.28
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 7.22
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 7.19
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 7.19
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.14
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 7.13
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 7.13
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 7.11
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 7.07
RNA sequencing of matched nephrectomy samples [RNA-seq] 7.07
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 6.99
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.96
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.93
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 6.83
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 6.83
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 6.81
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 6.77
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 6.76
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 6.69
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 6.61
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 6.61
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 6.6
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 6.53
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 6.48
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 6.46
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.44
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.44
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 6.42
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 6.41
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.38
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.34
RNA-seq analysis of BAP1-depleted uveal melanoma cells 6.33
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 6.33
Seletive inhibition of CDK9 in DLBCL cell lines 6.32
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 6.31
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 6.3
Differential responses of human fetal brain neural stem cells to Zika virus infection 6.28
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 6.27
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.19
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.19
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 6.08
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 6.06
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 6.04
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 5.97
Transcriptomic analysis of human tonsillar TFH subsets 5.97
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.94
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.94
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.9
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 5.89
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 5.89
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 5.85
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 5.85
METTL3 and WTAP 5.82
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.74
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 5.69
Anti-inflammatory effect of indoleacrylic acid (IA) 5.67
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.59
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.59
mRNA expression in human DAOY cells 5.59
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.56
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.53
A transcriptome dataset revealing the molecular features of breast cancer stem cells 5.45
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 5.45
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 5.42
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 5.4
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 5.4
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 5.38
Systematic discovery of endogenous human ribonucleoprotein complexes 5.37
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 5.35
HEK293 Heat-shock experiment 5.33
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 5.29
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 5.23
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 5.14
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 5.06
Metabolism as an early predictor of DPSCs aging 5.05
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.91
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 4.9
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.9
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.88
Zika virus directly infects human peripheral neurons and induces cell death 4.8
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.79
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.76
CD74 role in transcription regulation [RNA-seq] 4.76
CD74 role in transcription regulation 4.76
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 4.68
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 4.65
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 4.62
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 4.62
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 4.61
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 4.61
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.57
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 4.44
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.34
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 4.32
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.31
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.28
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.26
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 4.25
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.18
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 4.17
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 4.16
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.12
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 4.12
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.08
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 4.08
CD86 regulates a pro-survival signal in myeloma cells 4.07
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 4.06
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 4.01
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.0
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 3.98
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 3.84
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 3.84
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.78
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.76
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.76
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 3.67
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.65
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.6
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.58
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.57
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.57
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 3.55
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.42
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.39
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.38
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.31
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.28
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 3.23
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.22
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.21
RNA-Seq from human ILC transitional populations 3.21
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.17
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.1
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 2.93
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.91
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 2.91
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.87
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.87
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.84
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 2.74
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.7
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.69
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.69
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.69
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 2.62
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.59
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.59
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 2.55
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.49
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.47
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.47
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.45
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.45
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.41
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.41
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.4
hESC neural differentiation 2.4
RNA-seq analysis of gene expression patterns during hESC neural differentiation 2.4
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.39
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.39
RNA-seq data 2.36
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.34
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 2.27
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.21
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.2
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.04
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.04
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.04
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 2.02
Argonaute proteins couple chromatin silencing to alternative splicing 2.02
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.95
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.93
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.92
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.8
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.78
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.77
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.74
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.7
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.67
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.67
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.57
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.57
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.55
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.54
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.47
Transposon-based construction of strand-specific RNA-seq libraries 1.46
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.41
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.39
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 1.38
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 1.37
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.33
RNA-seq of IL-4 stimulated human keratinocytes 1.29
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.28
Human Treg IL-12 stimulation 1.27
Transcription elongation regulates genome 3D structure 1.22
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.22
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.2
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.19
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.18
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.13
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.08
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.08
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.06
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.01
RNA-seq of primary patient AML samples 0.96
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.95
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.95
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.91
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.91
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.86
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.86
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.84
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.82
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.78
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.74
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.71
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.69
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.69
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.62
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.58
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.56
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.55
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.55
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.53
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.53
High-resolution comparative analysis of great ape genomes 0.51
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.44
CHCHD2 gene KO effect in iPSC drived motor neurons 0.37
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.34
Total RNA-Seq data from leukemic patients with complex structural variants 0.28
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.28
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.25
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.24
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.2
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.17
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.15
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.15
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.14
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.11
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.1
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.1
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.05
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.04
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.02
Modulation of nonsense-mediated decay by rapamycin 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation